(Source: Business Wire)
AdvanSource Biomaterials Corporation (NYSE Amex: ASB), a leading
developer of advanced polymer materials for a broad range of medical
devices, today announced the recent filing of a patent for its newly
launched ChronoSil polymer product, a silicone-urethane copolymer. This
patent application relates to silicone-urethane copolymers and methods
for making ChronoSil. ChronoSil can have many physical properties which
are usually associated with polyurethanes, but also the feel and
characteristics of silicones.
The ChronoSil product family maintains the inherent benefits of a
polycarbonate-based urethane, including high pressure resistance,
tensile-strength and superior chemical resistance combined with
silicone's industry-recognized advantages such as heightened elongation,
superior elasticity and a low coefficient of friction.
Michael Adams, President and CEO, stated, "We were pleased to announce
our new biomaterial product, ChronoSil, a thermoplastic silicone
polycarbonate urethane, which was exhibited at the recent MEDTEC IRELAND
Medical Design and Manufacturing Exhibition and Conference in Galway,
Ireland. Two of the objectives that are key to our business strategy
include the development of innovative biomaterials to meet the needs of
medical device developers and manufacturers while building additional
value through a growing portfolio of patented products. This recent
patent application supports our commitment to both of these objectives.
We are pleased with the efforts of our research and development team and
look forward to continued innovation from this talented group of
scientists and engineers."
About AdvanSource Biomaterials
Corporation
AdvanSource Biomaterials Corporation manufactures advanced polymer
materials which provide critical characteristics in the design and
development of medical devices. The Company's biomaterials are used in
devices that are designed for treating a broad range of anatomical sites
and disease states. AdvanSource's business model leverages its
proprietary materials science technology and manufacturing expertise in
order to expand its product sales and royalty and license fee income.
More information about AdvanSource is available at its website: www.advbiomaterials.com
Forward-Looking Statements
AdvanSource believes that this press release contains forward-looking
statements as that term is defined in the Private Securities Litigation
Reform Act of 1995. Such forward-looking statements are based on
management's current expectations and are subject to risks and
uncertainties that could cause results to differ materially from the
forward-looking statements. For further information on such risks and
uncertainties, you are encouraged to review AdvanSource's filings with
the Securities and Exchange Commission, including its Annual Report on
Form 10-K for the fiscal year ended March 31, 2009 and its Quarterly
Report on Form 10-Q for the quarter ended June 30, 2009. AdvanSource
assumes no obligation to update any forward-looking statements as a
result of new information or future events or developments, except as
required by law.
A service of YellowBrix, Inc.
